2003 Clinical Trials Patients 
Greencamp
FEBRUARY 2, 2019
Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. 2003 ( 4 ). What is HIV and how is it manifested? How classical pharmaceuticals fight HIV.
Cannabis Info
OCTOBER 11, 2019
Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. Cannabis research in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 11, 2021
“More than 40,000 patients have used cannabis to treat their respective illnesses. These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Most are cancer patients.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.
Cannabis Law Report
JULY 25, 2022
Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. In 2003, Mr Robb was awarded the office of the Order of Australia (AO) for his service to agriculture, politics and the community.
Cannabis Law Report
FEBRUARY 10, 2022
Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). Petition for Review.
Otherside Farms
JANUARY 23, 2019
abst – 2003). 2003] – PubMed result. Inhibition of tumor angiogenesis by cannabinoids (full – 2003). Cannabinoids: Potential Anticancer Agents (full – 2003). A pilot clinical study of Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. abst – 2003).
Expert insights. Personalized for you.
110 
Let's personalize your content